Application of moutan bark derived carbon dots in preparation of medicine for treating myocarditis

CN119015343AActive Publication Date: 2024-11-26NANJING HOSPITAL OF TCM

Patent Information

Application Number
CN202411113196.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-11-26
Estimated Expiration
2044-08-14

Smart Images

  • Figure HDA0004992881910000011
    Figure HDA0004992881910000011
  • Figure HDA0004992881910000021
    Figure HDA0004992881910000021
  • Figure HDA0004992881910000022
    Figure HDA0004992881910000022
Patent Text Reader

Abstract

The invention discloses application of moutan bark derived carbon dots in preparation of a medicine for treating myocarditis. The moutan bark derived carbon dots (MCDs) obtained by high-temperature heating through a one-step hydrothermal method have good biocompatibility, show excellent ROS (reactive oxygen species) resistance in vivo and in vitro, and can remarkably remove OH, O2 <-> and < 1 > O2. The MCDs can effectively inhibit the oxidative damage and proinflammatory factor level of myocarditis cells and mice with acute myocarditis. The MCDs provided by the invention are easy to prepare and simple to synthesize, can improve the cardiac function of a mouse with acute myocarditis and effectively relieve myocardial damage, and provides a new technology and a new preparation for treating myocarditis.
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Traditional Chinese medicinal formula for treating myocarditis, and preparation method thereof

    CN107648487A

  • Carbon nanoparticles with blood cooling and hemostasis effects

    CN115475143A

  • Preparation method and application of traditional Chinese medicine carbon quantum dots for improving mangiferin performance

    CN116059382A

  • Preparation and application of cortex moutan nanoparticles

    CN117679454A

Cited By

  • Application of moutan bark derived carbon dots in treatment of acute myelogenous leukemia

    CN121796433A

  • Application of peony root-derived carbon dots in treatment of acute myeloid leukemia

    CN121796433B